StockData
Pure Bioscience, Inc. logo

Pure Bioscience, Inc. (PURE) stock

PUREOTCMiscellaneous Chemical ProductsFiscal year ends July 31
Financials through Q4 FY2026, quarter ended Jul 31, 2026Last filing: 10-K on Oct 29, 2026Score 1/30
$0.07−0.01 (-12.10%)

Close on Oct 19, 2026Market cap $8.67MP/E –Yield –

Pure Bioscience pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Pure Bioscience's pe ratio was 51.0× on May 28, 2021.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2021May 28, 202151.0×−27.0
2020Dec 31, 202078.0×–

More Pure Bioscience figures

See a number that looks wrong?